You are here

Article Text

Article menu
Download PDFPDF
Quality improvement
STAMP: a continuous improvement approach to improve paediatric prescribing and medication safety
  1. Katherine Styles1,
  2. Ashifa Trivedi2,
  3. Tristan Bate1,
  4. Richa Ajitsaria1
  1. 1 Department of Paediatrics, The Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UK
  2. 2 Divisional Pharmacist Women and Children, The Hillingdon Hospital NHS Foundation Trust, Uxbridge, UK
  1. Correspondence to Mrs. Ashifa Trivedi; ashifa.trivedi{at}nhs.net

Abstract

We describe an ongoing quality improvement project focusing on paediatric prescribing and medication safety for medical, surgical and oncology patients in a district general hospital. The project is called STAMP—Safe Treatment and Administration of Medicine in Paediatrics. The project has been running continuously for 24 months. No one factor has been identified to sustain a reduction in prescribing error rates. However, we have improved the quality and frequency of feedback to prescribers following errors. We believe that this ongoing project is changing the local prescribing culture, and with further Plan–Do–Study–Act cycles we hope to see improvement in prescribing error rates.

  • multidisciplinary team-care
  • paediatric practice

https://doi.org/10.1136/archdischild-2017-314286

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors RA and TB set up the STAMP project. AT has collected and analysed all data included in this manuscript. KS has been involved in STAMP for 6 months. KS and AT have coauthored the manuscript. All authors have reviewed and had input into the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    • Data sharing statement At the time this manuscript was uploaded for review, we now have data up to and including April 2018. As this project is ongoing, there will likely be new data collected from May 2018 onwards, but these are not yet available.